Jongmyung Kim, MD PhD (@jkimmdphd) 's Twitter Profile
Jongmyung Kim, MD PhD

@jkimmdphd

1John4:16, Thoracic Radiation Oncologist and Translational Scientist @MoffittNews. Assistant Professor @USFHealthMed. Views = my own.

ID: 1359673815622647808

linkhttps://www.moffitt.org/providers/jongmyung-kim/ calendar_today11-02-2021 01:21:28

215 Tweet

251 Takipçi

379 Takip Edilen

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Moffitt has been named a top 10 cancer hospital in America by Newsweek and Statista! Moffitt is also ranked No. 1 in Florida and the Southeast. View the full America’s Best Cancer Hospitals 2023 list ➡️ bit.ly/3NoJJSQ

Moffitt has been named a top 10 cancer hospital in America by Newsweek and Statista! Moffitt is also ranked No. 1 in Florida and the Southeast. View the full America’s Best Cancer Hospitals 2023 list ➡️ bit.ly/3NoJJSQ
Rutgers Cancer Institute (@rutgerscancer) 's Twitter Profile Photo

ICYMI: Rutgers Cancer Institute's Dr. Matthew Deek Matthew P Deek, Dr. Jongmyung Kim Jongmyung Kim, MD, PhD & colleagues presented “Exploring Genetic Changes in Aggressive Pancreatic Cancer” at #ASTRO23 cinj.org/exploring-gene… #radonc #pancreaticcancer #PancreaticCancerAwarenessMonth Rutgers RWJMedSchool RWJBarnabas

ICYMI: <a href="/RutgersCancer/">Rutgers Cancer Institute</a>'s Dr. Matthew Deek <a href="/matthewdeek/">Matthew P Deek</a>, Dr. Jongmyung Kim <a href="/JKimMDPhD/">Jongmyung Kim, MD, PhD</a> &amp; colleagues presented “Exploring Genetic Changes in Aggressive Pancreatic Cancer” at #ASTRO23
cinj.org/exploring-gene…
#radonc #pancreaticcancer #PancreaticCancerAwarenessMonth
<a href="/RWJMS/">Rutgers RWJMedSchool</a> <a href="/RWJBarnabas/">RWJBarnabas</a>
NEJM (@nejm) 's Twitter Profile Photo

Presented at #ESMO24: Among patients with limited-stage small-cell lung cancer, overall and progression-free survival were significantly longer with durvalumab adjuvant therapy added to standard concurrent chemoradiotherapy. Full ADRIATIC trial results: nej.md/4d0eZ5m

Presented at #ESMO24: 

Among patients with limited-stage small-cell lung cancer, overall and progression-free survival were significantly longer with durvalumab adjuvant therapy added to standard concurrent chemoradiotherapy. Full ADRIATIC trial results: nej.md/4d0eZ5m
USF Health (@usfhealth) 's Twitter Profile Photo

🥇 The University of South Florida Morsani College of Medicine ranks as the #1 medical school in #Florida and the only program in the state to earn a Tier 1 rating from U.S. News & World Report. This recognition ranks #USF among the Top 16 medical schools in the nation. #GoBulls 🔗 bit.ly/MCOMranking

🥇 The <a href="/USouthFlorida/">University of South Florida</a> Morsani College of Medicine ranks as the #1 medical school in #Florida and the only program in the state to earn a Tier 1 rating from <a href="/usnews/">U.S. News & World Report</a>. This recognition ranks #USF among the Top 16 medical schools in the nation. #GoBulls  
🔗 bit.ly/MCOMranking
Drew Moghanaki (@drewmoghanaki) 's Twitter Profile Photo

The thoracic surgery, medical, and radiation oncology team at the University of Pennsylvania presents their single-institutional experience at #ASTRO25 for patients with LA-NSCLC treated with neoadjuvant chemo-ICI, of whom 42% didn't proceed to surgery. Charu Aggarwal, MD, MPH, FASCO

The thoracic surgery, medical, and radiation oncology team at the University of Pennsylvania presents their single-institutional experience at #ASTRO25 for patients with LA-NSCLC treated with neoadjuvant chemo-ICI, of whom 42% didn't proceed to surgery. <a href="/CharuAggarwalMD/">Charu Aggarwal, MD, MPH, FASCO</a>
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Moffitt is proud to be at #ASTRO25! From radiation to proton therapy, our experts are showcasing innovations that are redefining what’s possible in cancer care. Visit Booth 3107, explore all our presentations at moffitt.org/ASTRO and follow #MoffittASTRO25 for live

Simran Polce, MD (@simranpolce) 's Twitter Profile Photo

Incredibly honored to be 1 of 12 residents in the country to receive a Recognition Meeting Abstract Award for our work on Adaptive Radiotherapy for Locally Advanced Lung Cancer. So thankful for my mentors and Moffitt Cancer Center for supporting our research. #ASTRO25

Incredibly honored to be 1 of 12 residents in the country to receive a Recognition Meeting Abstract Award for our work on Adaptive Radiotherapy for Locally Advanced Lung Cancer. So thankful for my mentors and Moffitt Cancer Center for supporting our research. #ASTRO25
OncoDaily (@oncodaily) 's Twitter Profile Photo

Excited to Co-Moderate a Joint Session on Immunotherapy and Lung Cancer With Houda Bahig (Houda Bahig, MD PhD) - Jongmyung Kim (Jongmyung Kim, MD, PhD) oncodaily.com/voices/jongmyu… #OncoDaily #Oncology #Cancer #Health #Medicine #Immunotherapy #LungCancer

Excited to Co-Moderate a Joint Session on Immunotherapy and Lung Cancer With Houda Bahig (<a href="/HoudaBahig/">Houda Bahig, MD PhD</a>) - Jongmyung Kim (<a href="/JKimMDPhD/">Jongmyung Kim, MD, PhD</a>)

oncodaily.com/voices/jongmyu…

#OncoDaily #Oncology #Cancer #Health #Medicine #Immunotherapy #LungCancer
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Happening now at #ASTRO25: Moffitt’s Jongmyung Kim, MD, (Jongmyung Kim, MD, PhD) moderates an educational session on clinical advances in immunotherapy + radiotherapy for NSCLC. Experts share insights on sequencing, dosing, toxicity, and translational research. View the presentations in

Happening now at #ASTRO25: Moffitt’s Jongmyung Kim, MD, (<a href="/JKimMDPhD/">Jongmyung Kim, MD, PhD</a>) moderates an educational session on clinical advances in immunotherapy + radiotherapy for NSCLC. Experts share insights on sequencing, dosing, toxicity, and translational research. 

View the presentations in
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

At #ASTRO25, Moffitt’s Kamran Ahmed, MD (Kamran Ahmed) & Jongmyung Kim, MD, PhD (Jongmyung Kim, MD, PhD) highlight practice-changing lung cancer research, including a phase III trial showing improved intracranial control with tumor treating fields + SRS for brain mets. #MoffittASTRO25

Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Live from #ASTRO25 in San Francisco: Kosj Yamoah, MD, PhD (Kosj Yamoah MD, PhD) chats with Simran Polce, MD (Simran Polce, MD), winner of quick pitch abstract award in cancer biology, on adaptive radiotherapy for lung cancer — safely escalating dose while reducing toxicity.

KoreanASTRO (@koreanastro) 's Twitter Profile Photo

Fantastic turnout at our first KASTRO/KOSTRO Joint Session at #ASTRO25! Special thanks to our speakers, Dr. Weon Kuu Chung, Dr. James Yu (James Yu), and Dr. Ji Hyun Chang (Ji Hyun Chang) for their fascinating talks on radiation therapy for Alzheimer's, OA, and V-Tach!

Fantastic turnout at our first KASTRO/KOSTRO Joint Session at #ASTRO25! Special thanks to our speakers, Dr. Weon Kuu Chung, Dr. James Yu (<a href="/jamesbyu/">James Yu</a>), and Dr. Ji Hyun Chang (<a href="/jihyunRadOnc/">Ji Hyun Chang</a>) for their fascinating talks on radiation therapy for Alzheimer's, OA, and V-Tach!
The Nobel Prize (@nobelprize) 's Twitter Profile Photo

BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”

BREAKING NEWS
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”